Exhibit 99.1

JACKSON ACQUISITION COMPANY

PRO FORMA BALANCE SHEET

		Actual as of December 13, 2021				Pro Forma Adjustments							As Adjusted
						(Unaudited)							(Unaudited)
ASSETS
Current Assets:
Cash		$	1,923,485			$	-						$	1,923,485
Prepaid expenses			26,435				-							26,435
Other current assets			380,000				-							380,000
Total Current Assets			2,329,920				-							2,329,920
Cash held in Trust Account			203,000,000				22,500,000			(a)				225,837,500
							787,500			(b)
							(450,000	)		(c)
Other assets			374,795				-							374,795
Total Assets		$	205,704,715			$	22,837,500						$	228,542,215
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued expenses		$	910,988			$	-						$	910,988
Accrued offering costs			399,000				-							399,000
Overallotment liability			420,760				(345,583	)		(e)				75,177
Total Current Liabilities			1,730,748				(345,583	)						1,385,165
Derivative warrant liabilities			25,819,200				2,524,500			(d)				28,343,700
Deferred underwriting commissions			7,000,000				787,500			(c)				7,787,500
Total Liabilities			34,549,948				2,966,417							37,516,365
COMMITMENTS AND CONTINGENCIES
Class A common stock subject to possible redemption; 20,000,000 and 22,250,000 shares (at $10.15 per share), actual and as adjusted, respectively			203,000,000				22,500,000			(a)				225,837,500
							337,500			(h)
Stockholders’ Deficit
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and Outstanding			-				-							-
Class A common stock, $0.0001 par value, 500,000,000 shares authorized, 0 shares issued and outstanding, actual and as adjusted (excluding 20,000,000 and 22,250,000 shares subject to possible redemption, actual and as adjusted, respectively)			-				-							-
Class B common stock, $0.0001 par value, 50,000,000 shares authorized, 5,750,000 and 5,562,500 shares issued and outstanding, actual and as adjusted, respectively			575				(19	)		(g)				556
Additional paid-in capital			-				787,500			(b)				-
							(1,237,500	)		(c)
							(2,272,500	)		(d)
							345,583			(e)
							80,552			(f)
							19			(g)
							(337,500	)		(h)
							2,633,846			(i)
Accumulated deficit			(31,845,808	)			(252,000	)		(d)				(34,812,206	)
							(80,552	)		(f)
							(2,633,846	)		(i)
Total Stockholders' Deficit			(31,845,233	)			(2,966,417	)						(34,811,650	)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit		$	205,704,715			$	22,837,500						$	228,542,215

JACKSON ACQUISITION COMPANY

Note to Pro Forma Balance Sheet

(unaudited)

NOTE 1 - CLOSING OF OVERALLOTMENT OPTION AND ADDITIONAL PRIVATE PLACEMENT

The accompanying unaudited Pro Forma Balance Sheet presents the Balance Sheet of Jackson Acquisition Company (the “Company”) as of December 13, 2021, adjusted for the closing of the partial exercise of the underwriter’s overallotment option and related transactions which occurred on January 6, 2022 as described below.

On January 6, 2022, the Company consummated the closing of the sale of 2,250,000 additional units (the “Over-Allotment Units”) at a price of $10.00 per Over-Allotment Unit upon receiving notice of the underwriter’s election to partially exercise its overallotment option, generating additional gross proceeds of $22,500,000 and incurring additional offering costs of $1,237,500 in underwriting fees.  Each Over-Allotment Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”), and one-half of one redeemable warrant (“Public Warrant”) of the Company. Each whole Public Warrant entitles the holder thereof to purchase one share of Class A Common Stock for $11.50 per share, subject to adjustment. Simultaneously with the closing of the partial exercise of the overallotment option, the Company consummated the private sale of an additional 787,500 warrants (the “Option Private Placement Warrants”) to RJ Healthcare SPAC, LLC (the “Sponsor”) at a purchase price of $1.00 per Option Private Placement Warrant, generating gross proceeds of $787,500. Of the additional $1,237,500 in underwriting fees, $787,500 is deferred until the completion of the Company’s initial business combination. As a result of the underwriter’s election to partially exercise its overallotment option, the Sponsor surrendered to the Company for cancellation 187,500 shares of the Company’s Class B common stock.

In connection with the closing and sale of the Over-Allotment Units and the Option Private Placement Warrants (together, the “Over-Allotment Closing”), a total of $22,837,500 in proceeds from the Over-Allotment Closing was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.

---